ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

ARTX Arotech Corporation

2.995
0.00 (0.00%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Arotech Corporation NASDAQ:ARTX NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 2.995 2.99 3.00 0 01:00:00

Moore Kuehn, PLLC Encourages Investors of SRC Energy, Inc. (SRCI), Achillion Pharmaceuticals, Inc. (ACHN), and Arotech Corpor...

22/11/2019 3:42pm

PR Newswire (US)


Arotech (NASDAQ:ARTX)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Arotech Charts.

NEW YORK, Nov. 22, 2019 /PRNewswire/ -- Moore Kuehn, PLLC, a securities law firm located on Wall Street in downtown New York City, is investigating potential claims involving the directors and officers regarding possible breaches of fiduciary duties and other violations of law related to merger and acquisition agreements.

(PRNewsfoto/Moore Kuehn, PLLC)

SRC Energy, Inc. (NYSE: SRCI)

SRC Energy, Inc. has agreed to be acquired by PDC Energy, Inc.  Under the terms of the agreement, SRC shareholders will receive a fixed exchange ratio of 0.158 PDC shares for each share of SRC common stock, representing an implied value of $3.99 per share based on the PDC closing price as of August 23, 2019.

Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN)

Achillion Pharmaceuticals has agreed to be acquired by Alexion.  The initial consideration of approximately $930 million, or $6.30 per share of Achillion common stock, will be funded with cash on hand. As part of the acquisition, Alexion will also be acquiring the cash currently on Achillion's balance sheet.

Arotech Corporation (NASDAQ: ARTX)

Arotech Corporation announced that it has entered into a definitive agreement with an affiliate of Greenbriar Equity Group, L.P. under which the affiliate will acquire all outstanding shares of Arotech common stock for $3.00 per share in cash, representing an aggregate equity value of approximately $80.8 million.

Moore Kuehn is investigating whether the Boards of the above companies 1) acted to maximize shareholder value, 2) failed to disclose material information, and 3) conducted a fair process.  Moore Kuehn may ultimately seek an increased share price, additional disclosures, or other relief and benefits on behalf of the shareholders of these companies. 

Moore Kuehn encourages shareholders to contact Fletcher Moore, Esq. by email at fmoore@moorekuehn.com or telephone at (212) 709-8245.  There is no cost or obligation to you. 

Moore Kuehn is a New York-based law firm with attorneys representing investors and consumers in class action litigation involving securities law violations, financial fraud, breaches of fiduciary duties, and other claims.  For additional information about Moore Kuehn, please go to http://www.moorekuehn.com/practice/new-york-securities-litigation/.

Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts:
Moore Kuehn, PLLC
Fletcher Moore, Esq.
30 Wall Street, 8th Floor
New York, New York 10005
fmoore@moorekuehn.com
(212) 709-8245

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/moore-kuehn-pllc-encourages-investors-of-src-energy-inc-srci-achillion-pharmaceuticals-inc-achn-and-arotech-corporation-artx-to-contact-firm-300963839.html

SOURCE Moore Kuehn, PLLC

Copyright 2019 PR Newswire

1 Year Arotech Chart

1 Year Arotech Chart

1 Month Arotech Chart

1 Month Arotech Chart

Your Recent History

Delayed Upgrade Clock